# Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa

> **NCT06738771** · — · RECRUITING · sponsor: **Centre Hospitalier Régional d'Orléans** · enrollment: 600 (estimated)

## Conditions studied

- Pseudomonas Infections
- Pseudomonas Aeruginosa
- Prognosis
- Drug Resistance, Multiple, Bacterial
- Antibacterial Agents
- Beta-lactam Antibiotics

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06738771
- **Lead sponsor:** Centre Hospitalier Régional d'Orléans
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-11
- **Primary completion:** 2027-01
- **Final completion:** 2027-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-04-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06738771

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06738771, "Antimicrobial Therapy for Difficult-to-treat Pseudomonas Aeruginosa". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06738771. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*